v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Cash flows from operating activities:          
Net loss $ (6,639,948) $ 17,931,827 $ (21,661,311) $ (50,366,134)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation     1,645,759 1,283,858  
Accretion of debt discount     30,076 401,610  
Amortization of debt issuance cost     530,645 486,758  
Capitalized paid-in-kind (PIK) interest     514,756 833,119  
Accretion of RCB Equities #1, LLC exit fee     73,418 73,058  
Stock-based compensation     968,240 1,872,504  
Change in fair value of warrant liabilities     (145,738) (13,347,829)  
Loss on extinguishment of debt 0 0 0 78,734,949  
Non-cash lease expense     294,324 314,859  
Gain on disposal of assets     0 (1,695)  
Write-off of property and equipment     0 32,636  
Gain on lease termination 0 0 0 (23,897)  
Changes in operating assets and liabilities:          
Accounts receivable     (1,003,549) (185,298)  
Inventories     41,146 (30,712)  
Other assets     307,486 1,542,915  
Accounts payable and accrued liabilities     (342,258) (4,256,864)  
Contract liabilities     (2,786) (2,070,095)  
Operating lease liabilities     (322,265) (203,486)  
Other liabilities     0 895,117  
Net cash used in operating activities     (18,943,935) (20,128,427)  
Cash flows from investing activities:          
Capital expenditures     (48,358) (466,712)  
Acquisition of business, net of cash acquired     (3,871,992) 0  
Proceeds from sale of assets held for sale     0 420,220  
Proceeds from sale of property and equipment     (500) 18,098  
Net cash used in investing activities     (3,920,850) (28,394)  
Cash flows from financing activities:          
Proceeds from notes payable     0 14,305,000  
Payment of debt issuance costs on notes payable     0 (1,316,791)  
Proceeds from ATM offering     24,377,196 9,857,857  
Payment of ATM commissions and fees     0 (499,903)  
Issuance of Series B Preferred Stock     2,855,000 0  
Repayment on notes payable     (61,108) 0  
Net cash provided by financing activities     27,171,088 22,346,163  
Effects of changes in exchange rates on cash and cash equivalents     0 (26,983)  
Net change in cash and cash equivalents     4,306,303 2,162,359  
Cash and cash equivalents, beginning of period     1,186,047 753,398 $ 753,398
Cash and cash equivalents, end of period 5,492,350 2,915,757 5,492,350 2,915,757 1,186,047
Supplemental disclosure of cash flow information:          
Cash paid for interest     109,015 135,089  
Cash paid for taxes     0 0  
Non-cash investing and financing activities:          
Conversion of 2024 Term Loan notes and interest to Common Stock     2,870,573 0  
Earnout shares for acquisition 6,864,729 0 6,864,729 0  
Debt assumed in acquisition     2,437,743 0  
Accrued purchase price 3,655,086 0 3,655,086 0 $ 0
Deemed dividend from down-round adjustment     3,427,706 0  
Operating leases at inception     0 1,095,067  
Exercise of warrants     0 4,635,256  
Fair value of conversion of convertible secured debentures to common stock   6,279,627 0 9,765,272  
Liabilities relieved through sale of asset held for sale     0 1,158,609  
Transfer from assets held for sale to property and equipment     0 1,119,864  
November 2024 Debentures          
Adjustments to reconcile net loss to net cash used in operating activities:          
Fair value adjustment of convertible debt (407,938) 0 128,122 0  
New Convertible Secured Debentures          
Adjustments to reconcile net loss to net cash used in operating activities:          
Fair value adjustment of convertible debt $ 0 $ (24,199,071) $ 0 $ (36,113,800)  

Source

PDF HTML 10-Q Filing
ZIP HTML XBRL